Safety and Efficacy Study of Dutogliptin in Subjects With Type 2 Diabetes Mellitus on a Background Medication of Metformin
NCT00998686 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 650
Last updated 2010-08-11
Summary
The purpose of this study is to demonstrate the safety and tolerability of dutogliptin over 52 weeks.
Conditions
Interventions
- DRUG
-
dutogliptin
400 mg
- DRUG
-
sitagliptin
100 mg
Sponsors & Collaborators
-
Forest Laboratories
collaborator INDUSTRY -
Phenomix
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-11-30
- Primary Completion
- 2011-10-31
- Completion
- 2011-11-30
Countries
- United States
- Argentina
- Czechia
- India
- Peru
- Poland
Study Locations
More Related Trials
-
A Study to Evaluate the Safety and Efficacy of Sitagliptin 100 mg in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control (MK-0431-229)
NCT01076075 ·Status: COMPLETED ·Phase: PHASE3
-
Sitagliptin Metformin Add-on Study in Patients With Type 2 Diabetes Mellitus
NCT00337610 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Evogliptin add-on to Metformin in Patients With type2 Diabetes
NCT02949193 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the Efficacy and Safety of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes
NCT03495102 ·Status: COMPLETED ·Phase: PHASE3
-
Long-term Extension Study to Evaluate the Safety of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus
NCT01101945 ·Status: TERMINATED ·Phase: PHASE2
-
Study of Safety and Efficacy of PF-04991532 in Subjects With Type 2 Diabetes
NCT01338870 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess the Addition of Sitagliptin to Metformin Compared With the Addition of Dapagliflozin to Metformin in Participants With Type 2 Diabetes Mellitus (T2DM) and Mild Renal Impairment Who Have Inadequate Glycemic Control on Metformin With or Without a Sulfonylurea (MK-0431-838)
NCT02532855 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Evogliptin When Added to Ongoing Metformin and Dapagliflozin Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control
NCT04170998 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Diet/Exercise Therapy (0431-054)(COMPLETED)
NCT00411554 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Assess the Efficacy and Safety of Sitagliptin Added to the Regimen of Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (0431-189)
NCT00875394 ·Status: COMPLETED ·Phase: PHASE3
-
Sitagliptin Comparative Study in Patients With Type 2 Diabetes (0431-049)
NCT00449930 ·Status: COMPLETED ·Phase: PHASE3
-
Sitagliptin Added-on to Insulin Study (0431-051)
NCT00395343 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Test the Safety and Efficacy of Sitagliptin Compared to Glimepiride in Patients With Type 2 Diabetes on a Stable Dose of Metformin (0431-803)(COMPLETED)
NCT00701090 ·Status: COMPLETED ·Phase: PHASE3
-
Safety/Efficacy of Sitagliptin in Patient w/ Type 2 Diabetes (0431-801)
NCT00541775 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Assess the Efficacy and Safety of Sitagliptin in Recently Diagnosed, Naive Type 2 Diabetics With Inadequate Glycemic Control on Diet and Exercise (0431-158)
NCT00832390 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of Saxagliptin Plus Insulin With or Without Metformin
NCT00757588 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Co-Administration of Sitagliptin and Metformin in China (MK-0431-121)
NCT01076088 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2330672 Administered With Metformin to Type 2 Diabetes Patients
NCT02202161 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Effects of Sitagliptin (MK0431) and Metformin on Incretin Hormone Concentrations (0431-050)(COMPLETED)
NCT00975052 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of Sitagliptin Compared With Glimepiride in Elderly Participants With Type 2 Diabetes Mellitus (MK-0431-251)
NCT01189890 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin in Combination With Metformin Compared to Sitagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Therapy Alone
NCT02284893 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Sitagliptin for the Treatment of Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0431-260)
NCT01462266 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase 3 Study of HS-20094 in Patients With T2DM
NCT07156539 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Efficacy and Safety of Vildagliptin in Combination With Metformin in Patients With Type 2 Diabetes
NCT00099892 ·Status: COMPLETED ·Phase: PHASE3
-
A Study in China Evaluating the Safety and Efficacy of Adding Sitagliptin to Stable Therapy With Insulin With or Without Metformin in Participants With Type 2 Diabetes Mellitus (T2DM) (MK-0431-254)
NCT01590797 ·Status: COMPLETED ·Phase: PHASE3